Published in Blood on October 01, 2000
How I treat refractory acute GVHD. Blood (2007) 2.05
Tocilizumab for the treatment of steroid refractory graft-versus-host disease. Biol Blood Marrow Transplant (2011) 1.37
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey. Leukemia (2015) 1.19
Aberrant B-cell homeostasis in chronic GVHD. Blood (2015) 1.06
Immunotherapy of systemic sclerosis. Immunotherapy (2010) 1.03
Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells. Apoptosis (2010) 1.01
Current and future approaches for control of graft-versus-host disease. Expert Rev Hematol (2008) 0.95
Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am (2010) 0.94
Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion. Ther Adv Hematol (2013) 0.93
Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease. Expert Opin Pharmacother (2008) 0.87
Clinical Results of Extracorporeal Photopheresis. Transfus Med Hemother (2012) 0.87
Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol (2014) 0.85
Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant (2009) 0.84
Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant (2009) 0.83
Modern aspects of phototherapy for atopic dermatitis. J Allergy (Cairo) (2011) 0.80
Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Blood (2016) 0.78
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. ScientificWorldJournal (2011) 0.78
Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease. Stem Cells (2016) 0.78
Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure. Haematologica (2014) 0.77
Modified extracorporeal photopheresis with cells from a healthy donor for acute graft-versus-host disease in a mouse model. PLoS One (2014) 0.77
Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature. Bone Marrow Transplant (2014) 0.77
Extracorporeal photo-apheresis for the treatment of steroid-resistant graft versus host disease. Transfus Apher Sci (2009) 0.77
Management of acute graft-versus-host disease in children. Pediatr Clin North Am (2010) 0.76
Systematic review and meta-analysis of prospective studies for ECP treatment in patients with steroid-refractory acute GVHD. Patient Prefer Adherence (2015) 0.75
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis. J Cancer Res Clin Oncol (2016) 0.75
Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science (1997) 5.40
Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet (2001) 3.70
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
[Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides]. Biomed Biochim Acta (1984) 2.80
Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell (2000) 2.77
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70
Polypeptide flux through bacterial Hsp70: DnaK cooperates with trigger factor in chaperoning nascent chains. Cell (1999) 2.33
Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol (1981) 2.28
Side-chain effects on peptidyl-prolyl cis/trans isomerisation. J Mol Biol (1998) 2.21
Catalysis of protein folding by prolyl isomerase. Nature (1987) 2.21
Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. Arch Dermatol (1999) 2.19
Phototesting and dosimetry for photochemotherapy. Br J Dermatol (1977) 2.17
Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med (1999) 2.14
Characterization of cspB, a Bacillus subtilis inducible cold shock gene affecting cell viability at low temperatures. J Bacteriol (1992) 2.04
A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics (1999) 2.00
Different keratin polypeptides in epidermis and other epithelia of human skin: a specific cytokeratin of molecular weight 46,000 in epithelia of the pilosebaceous tract and basal cell epitheliomas. J Cell Biol (1982) 1.93
[Psychotherapy research--how it should (not) be done. An expert reanalysis of comparative studies by Grawe et al. (1994)]. Psychother Psychosom Med Psychol (1998) 1.92
Photochemotherapy for psoriasis with orally administered methoxsalen. Arch Dermatol (1976) 1.89
Paternal age effect in Down's syndrome. Ann Hum Genet (1977) 1.84
Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry (1998) 1.80
A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor. EMBO J (1995) 1.79
Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med (1984) 1.75
The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase. Biochim Biophys Acta (1985) 1.75
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol (2011) 1.75
Nonprolyl cis peptide bonds in unfolded proteins cause complex folding kinetics. Nat Struct Biol (2001) 1.74
Incidence study of Down's syndrome in Copenhagen, 1960-1971; with chromosome investigation. Ann Hum Genet (1976) 1.72
The L2/HNK-1 carbohydrate of neural cell adhesion molecules is involved in cell interactions. J Cell Biol (1988) 1.67
Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor. Lancet (1997) 1.63
Treatment of opioid dependence in pregnant women. Addiction (2000) 1.63
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol (1991) 1.60
Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur J Biochem (1990) 1.60
Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res (2010) 1.60
Enzymes that catalyse the restructuring of proteins. Curr Opin Struct Biol (2000) 1.58
Percutaneous nonangiographic insertion of Hickman catheters in marrow transplant recipients by anesthesiologists and intensivists. Anesth Analg (1997) 1.58
Human epidermal T cells predominantly belong to the lineage expressing alpha/beta T cell receptor. J Exp Med (1990) 1.57
Confirmation of the existence of a third family among peptidyl-prolyl cis/trans isomerases. Amino acid sequence and recombinant production of parvulin. FEBS Lett (1994) 1.56
Catalysis of protein folding by cyclophilins from different species. J Biol Chem (1991) 1.56
Permeability of the epidermis and the phagocytic activity of keratinocytes. Ultrastructural studies with thorotrast as a marker. J Ultrastruct Res (1971) 1.55
Neurite outgrowth patterns in cerebellar microexplant cultures are affected by antibodies to the cell surface glycoprotein L1. J Neurosci (1986) 1.55
Cooperation of enzymatic and chaperone functions of trigger factor in the catalysis of protein folding. EMBO J (1997) 1.49
Continuous spinal anesthesia versus continuous femoral nerve block for elective total knee replacement. Minerva Anestesiol (2011) 1.48
Treatment of psoriatic arthritis by extracorporeal photochemotherapy. Br J Dermatol (1990) 1.47
Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. Arch Dermatol (1999) 1.46
A selective imaging of tinnitus. Neuroreport (1999) 1.44
Further evidence for lymphokine overproduction in severe aplastic anemia. Blood (1988) 1.43
Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells. Infect Immun (1995) 1.42
Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis. J Am Acad Dermatol (1987) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol (1988) 1.41
Abnormal epidermal changes after argon laser treatment. J Am Acad Dermatol (1991) 1.40
Severe sun sensitivity and the presence of antinuclear antibodies in patients with polymorphous light eruption-like lesions. A form fruste of photosensitive lupus erythematosus? J Am Acad Dermatol (1992) 1.40
Inborn errors of lipid metabolism--dermatological aspects. Clin Exp Dermatol (1988) 1.40
A revision of Pheidole Westwood (Hymenoptera: Formicidae) in the islands of the southwest Indian Ocean and designation of a neotype for the invasive Pheidole megacephala. Zootaxa (2013) 1.39
Giant cephalhaematoma in a 17-year-old boy with Ehlers-Danlos syndrome. Br J Neurosurg (1998) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Half-side comparison of erythemogenic versus suberythemogenic UVA doses in oral photochemotherapy of psoriasis. J Am Acad Dermatol (1999) 1.38
[Photochemotherapy of psoriasis: clinical experiences with 152 patients (author's transl)]. Dtsch Med Wochenschr (1975) 1.38
The unstable region of Streptomyces ambofaciens includes 210 kb terminal inverted repeats flanking the extremities of the linear chromosomal DNA. Mol Microbiol (1996) 1.37
Immunophilins: structure-function relationship and possible role in microbial pathogenicity. Mol Microbiol (1993) 1.36
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure (1997) 1.34
Dynamic MRI scan plane control for passive tracking of instruments and devices. Med Image Comput Comput Assist Interv (2007) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Conformational specificity of chymotrypsin toward proline-containing substrates. Biochim Biophys Acta (1984) 1.32
Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother (2009) 1.31
Crystal structure of Mip, a prolylisomerase from Legionella pneumophila. Nat Struct Biol (2001) 1.31
Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy. Am J Hum Genet (1981) 1.29
Enzyme histochemical analysis of cell viability after argon laser-induced coagulation necrosis of the skin. J Am Acad Dermatol (1991) 1.28
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant (2005) 1.28
A novel peptidyl-prolyl cis/trans isomerase from Escherichia coli. FEBS Lett (1994) 1.28
The activator of cerebroside sulphatase. Purification from human liver and identification as a protein. Hoppe Seylers Z Physiol Chem (1975) 1.26
Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. Biochemistry (1998) 1.24
Localized facial flushing in infancy. Auriculotemporal nerve (Frey) syndrome. Arch Dermatol (1997) 1.22
Mutations in a peptidylprolyl-cis/trans-isomerase gene lead to a defect in 3'-end formation of a pre-mRNA in Saccharomyces cerevisiae. J Biol Chem (1999) 1.22
Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine. Pharmacopsychiatry (1989) 1.22
Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood (1998) 1.21
Modular structure of the trigger factor required for high activity in protein folding. J Mol Biol (1997) 1.21
Kinetic analysis of cyclophilin-catalyzed prolyl cis/trans isomerization by dynamic NMR spectroscopy. Biochemistry (1995) 1.20
Induction of UV light tolerance by PUVA in patients with polymorphous light eruption. Br J Dermatol (1978) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Differential effects of DNA-binding proteins on bidirectional transcription from the common promoter region of human collagen type IV genes COL4A1 and COL4A2. Biochim Biophys Acta (1993) 1.19
Venous lakes (Bean-Walsh) of the lips--treatment experience with the argon laser and 18 months follow-up. Clin Exp Dermatol (1990) 1.16
Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas. Anticancer Res (1997) 1.15
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study. Leukemia (2011) 1.15
Regression of deeply infiltrating giant condyloma (Buschke-Löwenstein tumor) following long-term intralesional interferon alfa therapy. Arch Dermatol (2000) 1.15
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant (2002) 1.14
Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health. Bone Marrow Transplant (2008) 1.14
Natural distribution of 5 bacteria associated with periodontal disease. J Clin Periodontol (1993) 1.14
The Escherichia coli SlyD is a metal ion-regulated peptidyl-prolyl cis/trans-isomerase. J Biol Chem (1997) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Chest wall and intrathoracic desmoid tumors: surgical experience and review of the literature. Eur J Med Res (2009) 1.13